Loading peptide…
PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: CJC-1295 & Hexarelin, Mod GRF 1-29 & Hexarelin, Spartan 1
This blend combines CJC-1295 without DAC (Mod GRF 1-29), a GHRH analog, with Hexarelin, one of the most potent ghrelin-mimetic secretagogues, to drive a strong synergistic growth hormone pulse. Both are unapproved research peptides.
Sign in to rate this peptide.
CJC-1295 without DAC is a modified GHRH(1-29) analog that binds the pituitary GHRH receptor and increases the amplitude of natural growth-hormone pulses. Hexarelin is a synthetic hexapeptide GHS-R1a agonist that is among the most potent GHRPs for triggering GH release and suppressing somatostatin tone, and it also shows cardioprotective activity through the CD36 receptor. Combining a GHRH analog with Hexarelin produces a strong synergistic GH response via complementary receptor pathways. The short half-life of the no-DAC form preserves pulsatile GH and IGF-1 release; with prolonged Hexarelin exposure, GHS-R1a desensitization can attenuate the response over time.